Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -1.508% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: COc1ccc(NC(=O)C(NC(=O)c2ccc(=O)[nH]c2)c2ccc(OC)cc2)cc1
b: COc1cc(CC(=O)OCC(=O)Nc2cccc([N+](=O)[O-])c2)cc(OC)c1OC
Answer: a. COc1ccc(NC(=O)C(NC(=O)c2ccc(=O)[nH]c2)c2ccc(OC)cc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(NC(=O)C(NC(=O)c2ccc(=O)[nH]c2)c2ccc(OC)cc2)cc1
COc1ccc(NC(=O)C(NC(=O)c2ccc(=O)[nH]c2)c2ccc(OC)cc2)cc1
N-[2-(4-methoxyanilino)-1-(4-methoxyphenyl)-2-oxoethyl]-6-oxo-1H-pyridine-3-carboxamide